COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study

T. Chatzikonstantinou, A. Kapetanakis, L. Scarfo, G. Karakatsoulis, D. Allsup, A.A. Cabrero, M. Andres, D. Antic, M. Baile, P. Baliakas, D. Bron, A. Capasso, S. Chatzileontiadou, R. Cordoba, J.G. Correa, C. Cuellar-Garcia, L. De Paoli, M.R. De Paolis, G. Del Poeta, C. DemosthenousM. Dimou, D. Donaldson, M. Doubek, M. Efstathopoulou, B. Eichhorst, S. El-Ashwah, A. Enrico, B. Espinet, L. Farina, A. Ferrari, M. Foglietta, H. Frederiksen, M. Furstenau, J.A. Garcia-Marco, R. Garcia-Serra, M. Gentile, E. Gimeno, A. Glenthoj, M.G. da Silva, O. Gutwein, Y.K. Hakobyan, Y. Herishanu, J.A. Hernandez-Rivas, T. Herold, I. Innocenti, G. Itchaki, O. Jaksic, A. Janssens, O.B. Kalashnikova, E. Kalicinska, M. van Gelder, Kostas Stamatopoulos*, Paolo Ghia*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study'. Together they form a unique fingerprint.

INIS

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry

Nursing and Health Professions